Compound Sciences is a research peptide vendor that stepped in after Peptide Sciences shut down in 2026. It supplies short-chain amino acid compounds labeled ‘for research use only’ and targets labs, biohackers, and academic researchers seeking documented sourcing.
The company offers BPC-157, Retatrutide, Tirzepatide, TB-500, and GHK-Cu. Each batch comes with independent HPLC and mass spectrometry documentation. Purity verification is what separates trustworthy vendors from gray market sellers in this space, and that’s exactly what this review examines.
Read on for a full breakdown of what Compound Sciences is, what real users say, how it compares to alternatives, and whether the pricing holds up for serious research work.
What Is Compound Sciences?
Compound Sciences is a research peptide supplier that emerged in 2026 to fill the market gap created by the closure of Peptide Sciences, one of the most established vendors in the space. The company sells short chains of amino acids classified as research-grade compounds. All products carry a ‘for research use only’ label, meaning regulatory agencies haven’t approved them for human consumption.
Peptides are molecules composed of two or more amino acids linked by peptide bonds. They’re smaller than proteins and function as chemical messengers in biological systems. Scientists study them in controlled lab settings to understand how they interact with cellular receptors and downstream signaling pathways.
In fact, Stanford Medicine researchers note that consumer interest in peptides accelerated sharply alongside the success of FDA-approved GLP-1 drugs like Ozempic and Mounjaro. Compound Sciences positioned its catalog to serve the researcher and informed biohacker audience that was left without a trusted supplier after Peptide Sciences closed.
What Products Does Compound Sciences Offer?
Compound Sciences offers a research peptide catalog spanning metabolic signaling, tissue repair, and cognitive compound categories, with each product supplied as lyophilized powder and paired with independent third-party lab documentation. The lineup includes BPC-157, Retatrutide, Tirzepatide, MOTS-C, TB-500, GHK-Cu, Selank, and Semax. Reconstitution supplies like bacteriostatic water are also stocked.
The metabolic category includes compounds studied for energy and metabolic signaling pathways. Research peptides like Retatrutide and MOTS-C fall into this group. Scientists investigate their receptor interactions in vitro before any human application is considered.
Compound Categories:
- Metabolic Research: Retatrutide, Tirzepatide, MOTS-C, Tesamorelin
- Repair and Structural: BPC-157, TB-500 Blend, GHK-Cu
- Cognitive and Neuro: Selank, Semax
- Lab Supplies: Bacteriostatic Water, Sterile Water
Who Is Compound Sciences For?
Compound Sciences targets laboratory researchers, academic scientists, and informed biohackers who need purity-verified compounds with batch-level documentation for controlled study. The company isn’t positioned for general consumer wellness use. Every product page carries research-use disclaimers aligned with current regulatory expectations for this compound category.
Physicians and compounding pharmacists sometimes source peptides from vendors in this category for formulation research. Christopher Robinson, a physician-scientist at Johns Hopkins University specializing in chronic pain and regenerative medicine, notes that consistent purity documentation is essential for serious research work. Compound Sciences provides COAs per batch to support exactly this need.
How Does Compound Sciences Test Its Peptides?
Compound Sciences uses High-Performance Liquid Chromatography (HPLC) and mass spectrometry conducted by independent third-party labs to verify the purity and molecular identity of each peptide batch before release. Results are published in Certificates of Analysis organized by product and batch number. The full COA library is browsable on the company website before any purchase is placed.
Here’s how it works: HPLC separates the components of a peptide sample and measures their concentration. The method confirms that the target compound is present at the stated purity level. Mass spectrometry then verifies molecular weight and identifies any structural deviations from the intended sequence.
A 99% purity threshold is the minimum standard Compound Sciences applies across its catalog. Any batch failing this benchmark isn’t released for sale. This mirrors the practices of established research chemical suppliers across the industry who take documentation seriously.
Testing Methods Used:
- HPLC: Separates and quantifies compound components for purity confirmation
- Mass Spectrometry: Confirms molecular weight and structural identity
- Endotoxin Testing: Screens for contaminants that could skew research results
- COA Documentation: Published per batch, organized by product name and batch number
Does Compound Sciences Provide Third-Party COAs?
Yes. Compound Sciences publishes a Certificate of Analysis for every compound and every batch, organized by product name and batch number so buyers can verify identity, purity percentage, and molecular data before opening a vial. The COA library is publicly accessible. No login or prior purchase is required to review documentation before ordering.
Third-party COA verification is the single clearest signal separating legitimate peptide suppliers from gray market sources. Experts at Johns Hopkins University warn that unregulated vendors often skip independent documentation entirely. Compound Sciences addresses this concern directly by making batch-specific COAs publicly accessible at no barrier.
What Purity Standard Does Compound Sciences Use?
Compound Sciences maintains a minimum 99% purity standard for all compounds in its catalog, verified through HPLC and mass spectrometry by independent laboratories before any batch ships to customers. Each vial is lyophilized and sealed to preserve compound integrity during transit and storage. This purity level matches the benchmark used by established research chemical suppliers across the market.
Lyophilization, or freeze-drying, stabilizes peptides by removing water content. The process extends shelf life and prevents degradation that occurs in liquid form under variable temperature conditions. Compound Sciences ships compounds in this format to maintain quality through real-world transit.
The distinction between 99% purity and lower thresholds matters significantly in research contexts. Contaminants at even small concentrations can skew experimental results and introduce confounding variables. Independent mass spectrometry verification provides the additional confirmation layer that serious research environments require.
What Do Compound Sciences Reviews Say?
Compound Sciences has earned cautiously positive feedback from the research community, with users highlighting its COA library transparency, fast domestic shipping, and product variety as primary strengths. One published assessment describes the vendor as having ‘positioned themselves to fill the void left by legacy providers.’ Formal aggregate review data is limited given the company’s recent market entry after the 2026 Peptide Sciences closure.
Online forums and biohacking communities frequently evaluate peptide vendor quality against a consistent set of criteria. Consistent themes in Compound Sciences mentions include approval of batch-level documentation and the breadth of the compound catalog relative to competitors. Users compare the approach favorably to vendors offering only generic purity claims without batch-specific verification.
The limited volume of formal reviews reflects the niche nature of the research peptide market overall. Buyers in this space evaluate vendors primarily on COA transparency, shipping speed, and support responsiveness. Compound Sciences appears to perform well on all three criteria based on available community feedback.
What Positive Experiences Do Users Report?
Compound Sciences customers consistently highlight the accessible COA library, USPS Priority shipping speed, and responsive customer support as the top reasons for repeat purchases. Orders are described as arriving quickly in protective packaging designed to preserve compound integrity. Documentation is praised as easy to locate and verify before each purchase decision.
Shipping speed matters to researchers operating on defined experimental timelines. Compound Sciences uses USPS Priority Mail for domestic fulfillment. Most users report receipt within one to two business days of dispatch confirmation, which aligns with priority mail service standards.
What Are the Common Complaints About Compound Sciences?
Compound Sciences receives criticism from some buyers for its narrower catalog compared to legacy vendors and a track record shorter than competitors who predate the 2026 Peptide Sciences closure. A narrower catalog means certain specialized compounds aren’t available through the platform. Newer vendors also face inherent trust deficits compared to suppliers with years of community validation behind them.
To be clear, some complaints target the gray market peptide category as a whole rather than Compound Sciences specifically. Researchers at Stanford Medicine note that many peptides sold in this space lack human clinical data. This systemic limitation applies to all vendors operating outside FDA oversight, including every competitor Compound Sciences faces.
Pricing transparency is another area where early feedback suggests room for improvement. COA documentation is strong, but detailed per-milligram price comparisons with competitors aren’t prominently featured on the platform. Informed buyers typically compile this comparison themselves using competitor pricing pages.
Pros and Cons of Compound Sciences:
- Pro: Batch-level COA library is publicly accessible without a login
- Pro: 99% minimum purity standard verified by independent labs
- Pro: USPS Priority domestic shipping with protective packaging
- Pro: GLP-1 compounds available including Retatrutide and Tirzepatide
- Con: Narrower catalog than legacy vendors at peak
- Con: Limited formal review history predating 2026
- Con: Per-milligram price comparison tool not prominently featured
How Does Compound Sciences Compare to Competitors?
Compound Sciences competes in the research peptide market alongside Purgo Labs, King’s Compounds, and other post-Peptide Sciences vendors by emphasizing COA transparency, domestic fulfillment, and a growing GLP-1 compound catalog. The competitive landscape shifted significantly when Peptide Sciences closed in 2026. Vendors that quickly established verified documentation practices captured a large share of the displaced researcher base.
Vendors in this space are evaluated across a consistent rubric: purity verification, COA accessibility, shipping speed, and support quality. Compound Sciences performs competitively on purity documentation and fulfillment speed. New market entrants score lower on reputation due to limited community history, regardless of operational quality.
How Does Compound Sciences Compare to Peptide Sciences?
Compound Sciences serves a similar researcher customer base to what Peptide Sciences served before its 2026 shutdown, focusing on research-grade peptides with third-party purity verification and domestic delivery as core differentiators. Peptide Sciences was known for a broad catalog and strong community reviews before ceasing operations. Compound Sciences entered the market as a direct replacement for researchers needing a documented domestic supplier.
The shutdown of Peptide Sciences left many researchers without a trusted domestic peptide source overnight. Multiple vendors, including Compound Sciences and Purgo Labs, positioned themselves as alternatives. Buyers who previously ordered from Peptide Sciences compare new vendors primarily on COA quality and product breadth.
Compound Sciences offers a comparable COA framework to what Peptide Sciences maintained. The key difference is catalog depth. Peptide Sciences carried a broader range of compounds at the time of its closure. Compound Sciences continues to expand its catalog, but the full compound breadth hasn’t yet been replicated.
How Does Compound Sciences Compare to Purgo Labs?
Compound Sciences and Purgo Labs are both post-Peptide Sciences alternatives competing on COA transparency and GLP-1 compound availability, but they differ in catalog breadth and introductory pricing structure for new customers. Purgo Labs advertises an immediate 20% discount for new customers and a broader GLP-1 and longevity catalog. Compound Sciences counters with its accessible COA library and domestic shipping reliability.
Both vendors maintain COAs for their compound catalogs. Purgo Labs explicitly applies a 10-point vendor rubric and offers per-batch COA scoring. Compound Sciences structures its library by product and batch number for straightforward cross-reference without additional scoring overlays.
Compound Sciences vs Purgo Labs:
| Feature | Compound Sciences | Purgo Labs |
| Purity Standard | 99% minimum | 99% minimum |
| COA Access | Public library by batch | Public library, 10-point rubric |
| GLP-1 Compounds | Yes (Retatrutide, Tirzepatide) | Yes, broader longevity catalog |
| New Customer Discount | Not listed | 20% off first order |
| Shipping | USPS Priority domestic | US-based fulfillment |
| Track Record | Post-2026 entry | Post-2026 entry |
Buyers choosing between these two vendors typically base the decision on compound availability and first-purchase pricing. Researchers with specific compound needs check catalog alignment first. Those comparing overall value factor in shipping speed and support responsiveness alongside per-milligram cost.
Is Compound Sciences Legit?
Yes. Compound Sciences operates as a legitimate research peptide supplier with documented third-party purity testing, a publicly accessible COA library, and USPS Priority domestic shipping behind every order it processes. The company meets the standard criteria the research community uses to evaluate vendor legitimacy: transparent documentation, verifiable purity, and traceable batch records. No reports of fraudulent activity or misrepresented purity appear in available community assessments.
Legitimacy in the research peptide space is assessed differently from FDA-regulated pharmaceuticals. Vendors like Compound Sciences operate legally by selling compounds labeled ‘for research use only.’ This classification is distinct from pharmaceutical approval and doesn’t imply the compounds are safe for human use.
Community assessments cite no patterns of shipment failures, mislabeled compounds, or scam-adjacent behavior associated with Compound Sciences. The vendor maintains a browsable COA library, offers direct customer support, and provides batch-level documentation. These are recognized markers of a legitimate research supplier operating in this category.
Is Compound Sciences FDA Approved?
No. Compound Sciences is not FDA approved, and the research peptide compounds it sells are not FDA-approved drugs — they are classified as ‘for research use only’ and not intended for human consumption under any regulatory framework. FDA approval applies to specific drug formulations evaluated for safety and efficacy through clinical trials. Research chemicals sold by vendors like Compound Sciences operate entirely outside that regulatory structure.
The FDA does approve certain peptide-based drugs. Insulin, GLP-1 agonists like Ozempic and Mounjaro, and Pitocin are all FDA-approved examples. These compounds undergo rigorous clinical evaluation before approval. The research analogs sold by Compound Sciences haven’t gone through that process and carry no corresponding safety designation from any regulatory body.
Regulatory experts are direct on this risk. A Johns Hopkins researcher states that ‘anyone who uses them needs to understand the risks.’ Compound Sciences acknowledges this by labeling all products for research use only and refraining from making any therapeutic claims on its platform or marketing materials.
What Are the Side Effects of Compound Sciences Peptides?
Research peptides from vendors like Compound Sciences carry documented risk categories including contaminants, immune responses ranging from rashes to serious allergic reactions, and unknown long-term effects from any human application outside clinical trial conditions. The FDA’s Pharmacy Compounding Advisory Committee reviewed reports of contaminants and impurities in unregulated peptides during its 2026 deliberations. These risks apply to the research peptide category broadly, not to any single vendor’s products specifically.
Here’s why purity matters so much: impurities in injectable compounds trigger inflammatory or immune responses even at small concentrations. Research toxicologists note that endotoxins or trace contaminants produce measurable physiological effects. Third-party HPLC testing reduces this risk, but it doesn’t eliminate it entirely given the sensitivity limits of current testing protocols.
Peptide-specific risks vary significantly by compound. BPC-157 has a research history dating to the 1990s and a comparatively studied safety profile in animal models. Newer compounds like Retatrutide have only early clinical data in humans. Compound Sciences doesn’t provide dosing guidance or safety claims for any product in its catalog — and that’s legally correct for this product category.
Who Should Avoid Compound Sciences?
Anyone outside a legitimate research context should avoid purchasing from Compound Sciences, as the company sells compounds labeled ‘for research use only’ with no therapeutic indication or clinical safety data supporting human application. Medical professionals advise against self-administration of unregulated peptides. Consumers seeking wellness benefits should consult a licensed physician rather than sourcing directly from research vendors like this one.
People with known peptide allergies, autoimmune conditions, or who are pregnant or nursing face elevated risk categories from any unregulated peptide compound. The FDA advisory committee noted that peptides can provoke immune responses that vendors don’t adequately disclose. This documentation gap isn’t unique to Compound Sciences. It affects the entire research peptide vendor category without exception.
Stanford Medicine experts summarize the core problem: consumer demand for peptides has outpaced the science, regulation, and policy simultaneously. The ‘research use only’ label isn’t a consumer safety designation. Anyone without a genuine laboratory research purpose shouldn’t interpret it as permission to use these compounds for personal wellness goals.
How Much Does Compound Sciences Cost?
Compound Sciences prices its research peptides in line with the broader market, with compounds like BPC-157 typically ranging from $28 to $65 (USD) per vial depending on milligram quantity and current batch availability. GLP-1 analogs like Retatrutide and Tirzepatide command higher price points due to production complexity and elevated demand. Buyers should verify current pricing directly on the platform before ordering.
Per-milligram pricing is the standard comparison metric researchers use to evaluate vendor value. Retatrutide and Tirzepatide tend to land in the $80 to $120 (USD) per vial range. BPC-157 and TB-500 are generally more affordable given broader supply availability across multiple competing vendors.
Approximate Pricing by Category:
| Compound | Category | Typical Price Range (USD) |
| BPC-157 | Repair and Structural | $28 to $45 per vial |
| TB-500 Blend | Repair and Structural | $40 to $65 per vial |
| GHK-Cu | Repair and Structural | $35 to $55 per vial |
| Retatrutide | Metabolic Research | $80 to $120 per vial |
| Tirzepatide | Metabolic Research | $80 to $120 per vial |
| Selank / Semax | Cognitive and Neuro | $35 to $60 per vial |
Shipping costs add to the total order value. Compound Sciences uses USPS Priority Mail for domestic fulfillment. Orders below the free-shipping threshold carry a standard domestic fee, so buyers should factor shipping into per-compound cost comparisons before finalizing a vendor choice.
Is Compound Sciences Worth the Price?
Compound Sciences is worth the price for verified researchers who require documented purity and fast domestic delivery, because the publicly accessible COA library and independent testing justify the cost premium over undocumented alternatives. Cheaper vendors without COA transparency offer no way to verify what’s actually in the vial. For serious research, that documentation gap is the real cost — not the per-milligram savings.
Price-per-milligram alone is a poor metric for evaluating research peptide vendors. Purity verification, COA accessibility, batch traceability, and support quality all contribute to total research value. Compound Sciences performs well on the documentation metrics that matter most to professional researchers running controlled experiments.
Where Can You Buy Compound Sciences Peptides?
Compound Sciences peptides are available exclusively through the official Compound Sciences website, which processes orders with USPS Priority shipping and displays the full COA library for pre-purchase verification of every batch. No authorized third-party retail distribution is listed by the company. Buyers should be cautious of any resellers or listing sites claiming to offer Compound Sciences products through unofficial channels.
The official website provides compound-by-compound COA access, product descriptions, and ordering support. Payment options are listed at checkout. The company ships domestically and lists direct contact details for pre- and post-order support inquiries from researchers who need documentation or handling guidance.
Is Compound Sciences Worth Trying?
Compound Sciences is worth trying for researchers who prioritize third-party purity verification and domestic shipping speed, and who operate within a legitimate research framework that requires documented compound sourcing for every batch. The COA library, 99% purity standard, and USPS Priority fulfillment position it as a credible vendor in the post-Peptide Sciences market. Researchers seeking therapeutic benefits rather than controlled study should consult a licensed medical provider instead.
The vendor’s relative newness is its main limitation. Established suppliers like Purgo Labs have more community reviews and a broader catalog. Compound Sciences is building its track record and expanding its compound list. Researchers who value COA transparency over catalog breadth will find the offering competitive on the criteria that matter most in documented research work.
Bottom line: Compound Sciences operates legitimately, documents its compounds properly, and ships quickly. It fills a real gap left by the Peptide Sciences closure. For researchers with specific compound needs the catalog covers, it’s a solid choice in a market where documentation quality varies enormously across vendors.
Should You Try Compound Sciences for Your Research?
Researchers who need BPC-157, Retatrutide, GHK-Cu, or other listed compounds should strongly consider Compound Sciences as a primary or backup vendor due to its batch-level COA documentation and domestic USPS Priority fulfillment speed. The 99% purity standard and public COA library meet the documentation requirements that legitimate research contexts demand. Catalog coverage is the deciding factor: verify the specific compound is listed before committing.
The good news? Compound Sciences is actively expanding its catalog. Researchers who don’t find a specific compound today may find it listed within the next catalog update cycle. Checking the official website directly is the most reliable way to confirm current compound availability and batch-level COA status before placing an order.